ertugliflozin/metformin (Segluromet)

From Aaushi
Jump to navigation Jump to search
[1]

Indications

Dosage

  • BID oral dosing

Tabs: ertugliflozin/metformin

  • 2.5 mg/500 mg, 2.5 mg/1000 mg, 7.5 mg/500 mg, 7.5 mg/1000 mg.

More general terms

References

  1. ↑ Busko M FDA Approves SGLT2 Inhibitor Ertugliflozin for Type 2 Diabetes Medscape - Dec 21, 2017. https://www.medscape.com/viewarticle/890446
Retrieved from "https://aaushi.info/w/index.php?title=A54853&oldid=952266"